19 December 2018
Visiongain has launched a new pharma report Global Defibrillators Market Report : External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.
Defibrillators are essential in improving the quality of life and overall well-being. The defibrillators industry is highly competitive and diverse with immense potential growth. Drivers for growth include availability of technologically advanced defibrillators, rapidly growing aging population leading to high risk of cardiovascular diseases, growing incidence of cardiovascular diseases and increasing awareness and training programmes related to defibrillators.
The lead analyst of the report commented "Growth in this market is set to be driven by the availability of technologically advanced defibrillators, rapidly growing aging population leading to high risk of cardiovascular diseases, growing incidence of cardiovascular diseases and increasing awareness and training programmes related to defibrillators. However, lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavourable healthcare reforms in the U.S. are some of the key factors restraining the growth of this market. In addition to this, increasing pricing pressure on market players and frequent product recalls pose major challenges to defibrillator manufacturers."
Leading companies featured in the report include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, LivaNova PLC, Medtronic PLC, Nihon Kohden Corporation, Phillips Healthcare, Physio Control Inc., Zoll Medical Corporation.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.
19 April 2021
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
12 April 2021
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.